Analysis

July 20, 2023

The 9 biggest unannounced UK fundraises of 2023

More than two thirds of rounds go unannounced


While it might seem like most founders can’t wait to announce their latest funding round, more often than not startups keep quiet, according to research by data platform Beauhurst. 

68% of all fundraises in the UK go unannounced — with the majority of those “stealth” rounds happening at seed stage. And as the tricky economic headwinds push more companies to raise flat or downrounds — something few founders want to shout about — it’s likely that figure will rise in the coming months.  

Using data from Beauhurst and company filings, Sifted looked into the largest unannounced rounds in the UK of 2023 as of July 18. We haven’t included companies that have ceased trading or exited since raising. 

Advertisement

1/ Netomnia

Round size: £36m (Beauhurst data)
Round date: February
Total funding: £684m (Beauhurst data)
HQ: Tewkesbury

Netomnia is an internet infrastructure startup, building a fibre optic network across the UK. The £36m equity raise — which CEO Jeremy Chelot tells Sifted is an extension of its £295m raise in 2022 — was for a 10% stake in the business, according to Beauhurst. 

The company has also raised £230m in debt financing this year. 

2/ Quell Therapeutics

Round size: £19.9m (Beauhurst data)
Round date: June
Total funding: £198m (Beauhurst data)
HQ: London

Quell Therapeutics is developing tech to manipulate patients’ immune systems by engineering regulatory T-cells, which can help fight disease. 

The startup’s £19.9m equity round was part of a partnership with AstraZeneca that could be worth up to $2bn — which will see it collaborate on research and licence two of its treatments for autoimmune diseases to the pharma giant. AstraZeneca took a 9% stake in the company, according to Beauhurst.

The company confirmed there was an equity raise, but declined to comment on its size.

3/ All.Space

Round size: £18.8m (Beauhurst data)
Round date: July
Total funding: £124m (Beauhurst data)
HQ: Reading

Spacetech All.Space connects satellites and signal networks with its ground-based terminal — that helps the defence, aerospace and telecoms sectors boost connectivity. It raised £18.8m in July for a 19.2% stake in the business, according to Beauhurst.

The company declined to comment on the raise.

4/ Tide

Oliver Prill, CEO, Tide
Oliver Prill, CEO, Tide

Round size: £18.5m, confirmed by company
Round date: January
Total funding: £179m (Beauhurst data)
HQ: London

The neobank for businesses raised the £18.5m to (in part) fund its acquisition of business loan and cash management platform Funding Options, a spokesperson tells Sifted. The capital was raised from existing investors.  

5/ ManageMy

Round size: £17.6m, confirmed by company
Round date: June
Total funding: £23.3m (Beauhurst data)
HQ: London

Advertisement

Insurtech ManageMy provides a customer engagement platform for insurance companies. Ventura Capital led the round, which also featured a number of strategic investors, ManageMy tells Sifted. The £17.6m raise was worth a 17.9% stake in the business.

6/ Garrison Technology

Round size: £15.5m, confirmed by company
Round date: March
Total funding: £54.7m (Beauhurst data)
HQ: London

Garrison is a cybersecurity startup selling solutions to large organisations and governments. 

Its new funding will be spent on strengthening its business in the US — where it saw strong growth last year — and developing its suite of products, a company spokesperson tells Sifted.

7/ Shop Circle 

Round size: £14.9m (Beauhurst data)
Round date: April
Total funding: £69.3m (Beauhurst data)
HQ: London

Shop Circle buys up e-commerce sellers and helps them grow with its platform of user experience and shop management tools. Its £14.9m raise was worth a 23.6% stake in the business, according to Beauhurst. 

The company could not be reached for comment.

8/ Resolution Therapeutics

Round size: £14.9m (Beauhurst data)
Round date: April
Total funding: £58.5m (Beauhurst data)
HQ: Edinburgh

Resolution Therapeutics is a biotech developing treatments for inflammatory organ diseases via cell therapy. The raise was worth a 35.5% stake in the company, according to Beauhurst. The company last raised a £10m Series A in April 2022.

Resolution Therapeutics could not be reached for comment.

9/ Pollinate

Pollinate founders Al Lukies, Fiona Roach Canning, Jonathan Hughes and Tim Joslyn
Pollinate founders Al Lukies, Fiona Roach Canning, Jonathan Hughes and Tim Joslyn

Round size: £14.5m
Round date: March
Total funding: £135m
HQ: London

Pollinate is a SaaS startup that provides banks with a suite of digital tools to sell to merchants — including a payment management platform, digital loyalty schemes and marketing tools. 

Pollinate declined to comment on the raise.

Kai Nicol-Schwarz

Kai Nicol-Schwarz is a reporter at Sifted. He covers UK tech and healthtech, and can be found on X and LinkedIn